Research news
Summaries of recent peptide research and regulatory news, with links to the original reporting.
09/27/2026
Three recent peptide research stories: catestatin in preclinical neurodegeneration models, a first-in-human GRPR-targeted radiotherapy trial, and a large medical-records study of BPC-157 use.
June 4, 2026 · Pharmacy Times
HHS signaled that several peptides may move back to Category 1 for compounding while others stay restricted. The article stresses that reclassification only affects compounding legality. It is not FDA approval and does not establish dosing, indications or safety.
News summaries are provided for general information only and are not medical advice. All LuLu Peptides products are for laboratory research use only and are not for human or veterinary use.
LuLu Peptides
We sell research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm both statements to continue.
By continuing you confirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.
Not a researcher? Exit
